Skip to content
Main menu hidden.

Image: Mattias Pettersson

Erik Chorell lab

Research group Our approach is chemical biology and the development of new strategies for disrupting and studying complex biological processes to investigate their therapeutic potential.

The main focus of the lab is to use organic chemistry, medicinal chemistry, and chemical biology to explore new strategies to interfere with and study processes related to cancer biology.

This includes the development of small heterocyclic molecules but also new modalities in drug development such as oligonucleotides. The bioactive derivatives are designed using structure-based techniques or identified through screening-based strategies together with Chemical Biology Consortium Sweden (CBCS).

Most projects are interdisciplinary and collaborations with other research groups are common. 

Head of research

Erik Chorell
Associate professor


Participating departments and units at Umeå University

Department of Chemistry

Research area

Cancer, Chemical sciences

External funding

Swedish Research Council, The Kempe Foundation

External funding

The CBCS infrastructure selected to be part of EU research infrastructure

EU-OPENSCREEN integrates high-throughput screening platforms in chemical biology across Europe.

Umeå researchers discover molecule for cancer diagnostics

Four-stranded DNA associated with the onset of cancer can be detected with a fluorescent molecule.

Latest update: 2022-08-30